Meta Ad Library · GB,DE,FR,BR
What competitors are running.
Active Facebook + Instagram + Messenger ads from this app’s developer (and lookalike pages). Spend and impressions only show for EU/UK/BR-targeted ads under DSA disclosure.
Active Facebook + Instagram + Messenger ads from this app’s developer (and lookalike pages). Spend and impressions only show for EU/UK/BR-targeted ads under DSA disclosure.
2 Fixed Correct Scores 3 - 3 & 2 - 2 ⚽️ Today's Sure games confidence 100% 👇👇 https://t.me/+-_KT9szY_8AwNWY8 https://t.me/+-_KT9szY_8AwNWY8 https://t.me/+-_KT9szY_8AwNWY8
2 Fixed Correct Scores 3 - 3 & 2 - 2 ⚽️ Today's Sure games confidence 100% 👇👇 https://t.me/+gIfn7o5CCRVkNzg0 https://t.me/+gIfn7o5CCRVkNzg0
Advantage Gambling| Elite Prediction 🚨 3–1 ✅ | 1-0 ✅ – Scorelines Bang On! All games are safe and profitable ✅ Daily Correct Scores – FREE for new members! Don't miss today's tip—it's already available! Join now and get your first free game!
2 Fixed Correct Scores 3 - 3 & 2 - 2 ⚽️ Today's Sure games confidence 100% 👇👇 https://t.me/+RJRXtln8ZoMwMjQ0 https://t.me/+RJRXtln8ZoMwMjQ0
Some apps you download once and never delete. Slotlair is one of them. See why — £60 inside for new users. 🎁
Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons
Today two combine correct scores available for booking
Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons
Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons
Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons
Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons
Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons
Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons
Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons | Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons | Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons
Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons
Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons
Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons
Every cardiovascular supplement currently being marketed to you requires you to take it tomorrow. Not because your body is progressing toward something. Because it is not. Beetroot works while beetroot is in your system. The moment it clears the effect clears with it. Aged garlic protects your arteries from ongoing damage for as long as you take it. Stop taking it and the protection stops. Cacao dilates your vessels for two hours. Then it resets. Every one of them produces an effect that exists only in the presence of the compound. Remove the compound. Remove the effect. This means that the entire category of cardiovascular supplementation — as it is currently formulated and marketed — is not a treatment. It is a dependency. A daily dependency that the industry has no commercial incentive to resolve because a resolved dependency is a lost customer. A colleague of mine decided to find out whether any product in this category actually breaks that pattern. His name is James Hargreaves. He is an independent health researcher with no financial relationship to any supplement manufacturer. He spent the better part of two years asking one question about every major cardiovascular supplement on the market. Does the effect stay when the supplement does not. Not whether the ingredients are legitimate. They largely are. Not whether the research behind them is real. It largely is. But whether anything structural is actually changing in the vessel wall itself — or whether the customer is simply maintaining a daily dependency that the industry has no commercial incentive to resolve. What he found was a market almost perfectly organised around the commercially optimal outcome. Beetroot replaces the output of a broken mechanism without touching the mechanism itself. The effect clears within hours. The arterial wall on day 365 is structurally identical to day one. Aged garlic slows the ongoing damage that stiffens arteries but cannot reverse the stiffness already developed. Cacao flavanols produce real vasodilation for approximately two hours per dose. Nothing structural changes regardless of duration. Nattokinase at the doses available in almost every commercial product is below the clinically relevant threshold by a factor of five. Every one of these products requires you to take it tomorrow. Because nothing underneath has changed. The exception James identified was capsaicin. But with a critical caveat about delivery. Capsaicin is fat soluble. Consumed in a dry capsule it encounters stomach acid, breaks down, and clears before meaningful absorption occurs. Most cayenne products on the market are selling an ingredient that never reaches the bloodstream. The mechanism is correct. The delivery is not. And for capsaicin specifically, delivery is not a secondary consideration. It is the entire question. When capsaicin reaches the arterial wall in sufficient concentration through correct lipid-based delivery, it activates the cells lining the vessel wall to produce nitric oxide from within. Not borrowed from an external source the way beetroot provides it. Produced internally by the body's own cells through the mechanism that stopped working. With consistent daily activation those cells begin to physically recover elasticity. The change accumulates. The effect does not reset overnight because the effect is not in what is circulating. It is in the wall itself. This is the distinction James built his entire ranking around. Not ingredient quality. Not sourcing. Not third party testing — though he covers all of it. Whether the product produces change that persists or change that evaporates. Whether it is building something or substituting for something. His full analysis covers every major product in the category. He scores each one on active compounds, absorption and delivery, duration of effect, dose versus clinical evidence, and buyer confidence. He names specific products. He explains exactly where each one hits its ceiling and why no increase in dose or duration overcomes it. It is the most rigorous and commercially honest piece of analysis I have come across in this space. And it is the first thing I point patients toward when they ask me why what they have been taking has not moved the needle the way they expected. The link to his full supplement ranking is below. Read it before you spend another dollar on something that resets by morning. — Rachael Simmons
Caffeine is 1 nootropic. CONKA has 15... Science backed with effective dosages. Shop now at conka.io
Caffeine is 1 nootropic. CONKA has 15... Science backed with effective dosages. Shop now at conka.io
Caffeine is 1 nootropic. CONKA has 15... Science backed with effective dosages. Shop now at conka.io
Caffeine is 1 nootropic. CONKA has 15... Science backed with effective dosages. Shop now at conka.io
Caffeine is 1 nootropic. CONKA has 15... Science backed with effective dosages. Shop now at conka.io
Caffeine is 1 nootropic. CONKA has 15... Science backed with effective dosages. Shop now at conka.io
hello, get your correct scores here
Connect with Carlos correct scores
Connect with Carlos correct scores